# Lesinurad and Febuxostat Combination Extension Study in Gout

> **NCT01808144** · PHASE3 · COMPLETED · sponsor: **Ardea Biosciences, Inc.** · enrollment: 196 (actual)

## Conditions studied

- Gout

## Interventions

- **DRUG:** lesinurad
- **DRUG:** lesinurad
- **DRUG:** febuxostat

## Key facts

- **NCT ID:** NCT01808144
- **Lead sponsor:** Ardea Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-01
- **Primary completion:** 2016-08-09
- **Final completion:** 2016-10-06
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2018-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01808144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01808144, "Lesinurad and Febuxostat Combination Extension Study in Gout". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01808144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*